Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib
- Author(s)
- Bjoern Bielec, Hemma Schueffl, Alessio Terenzi, Walter Berger, Petra Heffeter, Bernhard K. Keppler, Christian R. Kowol
- Organisation(s)
- Department of Inorganic Chemistry
- External organisation(s)
- Medizinische Universität Wien, Donostia International Physics Centre (DIPC), Research Cluster Translational Cancer Therapy Research
- Journal
- Bioorganic Chemistry
- Volume
- 99
- No. of pages
- 10
- ISSN
- 0045-2068
- DOI
- https://doi.org/10.1016/j.bioorg.2020.103778
- Publication date
- 06-2020
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 104015 Organic chemistry, 301904 Cancer research, 106002 Biochemistry, 106023 Molecular biology
- Keywords
- ASJC Scopus subject areas
- Drug Discovery, Molecular Biology, Biochemistry, Organic Chemistry
- Sustainable Development Goals
- SDG 3 - Good Health and Well-being
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/c49eeb92-4b10-4002-aac8-a0296efef532